Markets

Sector Update: Healthcare; AEterna Zentaris Reports Earnings

Healthcare stocks were mostly advancing in afternoon trading, with the S&P/TSX Healthcare index gaining 0.5%.

Valeant Pharmaceuticals (VRX.TO): +0.3%

Catamaran (CCT.TO): +2.7%

Concordia Healthcare (CXR.TO): -5.2%

AEterna Zentaris (AEZ.TO): +1.8%

Oncolytics Biotech (ONC.TO): -4.8%

In corporate news, AEterna Zentaris late Thursday said it swung to a net loss of $4.4 million, or $0.08 per diluted share, in Q1 ended March 31, 2014 from a net income of $1.9 million, or $0.07 per diluted share, a year earlier. The specialty biopharmaceutical company had no revenue during the period due to the non-recurring, accelerated recognition of remaining unamortized deferred revenue related to an upfront payment received from a licensing partner following the termination of related R&D activities. Revenue last year was $6.1 million.

Cash and cash equivalents totaled $45.8 million as at March 31, 2014, compared to $43.2 million as at December 31, 2013.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More